Clive A. Meanwell
2013
In 2013, Clive A. Meanwell earned a total compensation of $4.6M as Chief Executive Officer at Medicines, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $842,852 |
|---|---|
| Option Awards | $878,096 |
| Salary | $793,272 |
| Stock Awards | $2,057,997 |
| Other | $3,354 |
| Total | $4,575,571 |
Meanwell received $2.1M in stock awards, accounting for 45% of the total pay in 2013.
Meanwell also received $842.9K in non-equity incentive plan, $878.1K in option awards, $793.3K in salary and $3.4K in other compensation.
Rankings
In 2013, Clive A. Meanwell's compensation ranked 1,441st out of 12,286 executives tracked by ExecPay. In other words, Meanwell earned more than 88.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,441 out of 12,286 | 88th |
Division Manufacturing | 464 out of 4,612 | 90th |
Major group Chemicals And Allied Products | 124 out of 1,466 | 92nd |
Industry group Drugs | 82 out of 1,160 | 93rd |
Industry Pharmaceutical Preparations | 73 out of 890 | 92nd |
Source: SEC filing on April 25, 2016.
Meanwell's colleagues
We found three more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2013.